Crichlow GV - Search Results

1

Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.

Crichlow GV, Kuzin AP, Nukaga M, Mayama K, Sawai T, Knox JR. Crichlow GV, et al. Biochemistry. 1999 Aug 10;38(32):10256-61. doi: 10.1021/bi9908787. Biochemistry. 1999. PMID: 10441119

2

Structure of an extended-spectrum class A beta-lactamase from Proteus vulgaris K1.

Nukaga M, Mayama K, Crichlow GV, Knox JR. Nukaga M, et al. Among authors: crichlow gv. J Mol Biol. 2002 Mar 15;317(1):109-17. doi: 10.1006/jmbi.2002.5420. J Mol Biol. 2002. PMID: 11916382

3

Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.

Crichlow GV, Nukaga M, Doppalapudi VR, Buynak JD, Knox JR. Crichlow GV, et al. Biochemistry. 2001 May 29;40(21):6233-9. doi: 10.1021/bi010131s. Biochemistry. 2001. PMID: 11371184

4

Crystallization and preliminary X-ray study of OXA-1, a class D beta-lactamase.

Sun T, Nukaga M, Mayama K, Crichlow GV, Kuzin AP, Knox JR. Sun T, et al. Among authors: crichlow gv. Acta Crystallogr D Biol Crystallogr. 2001 Dec;57(Pt 12):1912-4. doi: 10.1107/s0907444901016274. Epub 2001 Nov 21. Acta Crystallogr D Biol Crystallogr. 2001. PMID: 11717515

5

Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.

Crichlow GV, Lubetsky JB, Leng L, Bucala R, Lolis EJ. Crichlow GV, et al. Biochemistry. 2009 Jan 13;48(1):132-9. doi: 10.1021/bi8014423. Biochemistry. 2009. PMID: 19090677 Free PMC article.

6

Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.

Crichlow GV, Cheng KF, Dabideen D, Ochani M, Aljabari B, Pavlov VA, Miller EJ, Lolis E, Al-Abed Y. Crichlow GV, et al. J Biol Chem. 2007 Aug 10;282(32):23089-95. doi: 10.1074/jbc.M701825200. Epub 2007 May 25. J Biol Chem. 2007. PMID: 17526494 Free PMC article.

7

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME, Bucala R, Cappello M, Gross M, Gaeta F, Johnson K, Lolis EJ. Cho Y, et al. Among authors: crichlow gv. Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11313-8. doi: 10.1073/pnas.1002716107. Epub 2010 Jun 8. Proc Natl Acad Sci U S A. 2010. PMID: 20534506 Free PMC article.

8

A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.

Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, Bucala R, Leng L, Smith N, Lolis E, Trent JO, Mitchell RA. Winner M, et al. Among authors: crichlow gv. Cancer Res. 2008 Sep 15;68(18):7253-7. doi: 10.1158/0008-5472.CAN-07-6227. Cancer Res. 2008. PMID: 18794110 Free PMC article.

9

ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.

Ioannou K, Cheng KF, Crichlow GV, Birmpilis AI, Lolis EJ, Tsitsilonis OE, Al-Abed Y. Ioannou K, et al. Among authors: crichlow gv. Int J Oncol. 2014 Oct;45(4):1457-68. doi: 10.3892/ijo.2014.2551. Epub 2014 Jul 22. Int J Oncol. 2014. PMID: 25050663 Free PMC article.

10

Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.

Crichlow GV, Zhou H, Hsiao HH, Frederick KB, Debrosse M, Yang Y, Folta-Stogniew EJ, Chung HJ, Fan C, De la Cruz EM, Levens D, Lolis E, Braddock D. Crichlow GV, et al. EMBO J. 2008 Jan 9;27(1):277-89. doi: 10.1038/sj.emboj.7601936. Epub 2007 Dec 6. EMBO J. 2008. PMID: 18059478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters